CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2023		32,023,004
Beginning balance at Dec. 31, 2023	$ 1,233,397	$ 32	$ 736,191	$ 495,383	$ 1,791
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	11,699			11,699
Unrealized loss on investment, net of tax	(442)				(442)
Stock-based compensation	1,529		1,538	(9)
Issuance of restricted and deferred stock units (in shares)		30,432
Issuance of restricted and deferred stock units	(1,215)		(1,215)
Employee stock purchase plan (in shares)		21,755
Employee stock purchase plan	1,101		1,101
Common stock issuance, net of costs (in shares)		126,025
Common stock issuance, net of costs	7,006		7,006
Dividends paid	(12,824)			(12,824)
Ending balance (in shares) at Mar. 31, 2024		32,201,216
Ending balance at Mar. 31, 2024	1,240,251	$ 32	744,621	494,249	1,349
Beginning balance (in shares) at Dec. 31, 2023		32,023,004
Beginning balance at Dec. 31, 2023	1,233,397	$ 32	736,191	495,383	1,791
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	32,395
Ending balance (in shares) at Jun. 30, 2024		32,668,904
Ending balance at Jun. 30, 2024	1,274,608	$ 33	771,189	502,037	1,349
Beginning balance (in shares) at Mar. 31, 2024		32,201,216
Beginning balance at Mar. 31, 2024	1,240,251	$ 32	744,621	494,249	1,349
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	20,696			20,696
Stock-based compensation	1,267		1,275	(8)
Issuance of restricted and deferred stock units (in shares)		9,083
Issuance of restricted and deferred stock units	(2)		(2)
Common stock issuance, net of costs (in shares)		458,605
Common stock issuance, net of costs	25,296	$ 1	25,295
Dividends paid	(12,900)			(12,900)
Ending balance (in shares) at Jun. 30, 2024		32,668,904
Ending balance at Jun. 30, 2024	$ 1,274,608	$ 33	771,189	502,037	1,349
Beginning balance (in shares) at Dec. 31, 2024	33,629,169	33,629,169
Beginning balance at Dec. 31, 2024	$ 1,366,974	$ 34	827,796	537,184	1,960
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	16,551			16,551
Stock-based compensation	1,201		1,210	(9)
Issuance of restricted and deferred stock units (in shares)		31,587
Issuance of restricted and deferred stock units	(908)		(908)
Employee stock purchase plan (in shares)		26,129
Employee stock purchase plan	1,116		1,116
Common stock issuance, net of costs (in shares)		495,900
Common stock issuance, net of costs	26,545		26,545
Dividends paid	(14,142)			(14,142)
Ending balance (in shares) at Mar. 31, 2025		34,182,785
Ending balance at Mar. 31, 2025	$ 1,397,337	$ 34	855,759	539,584	1,960
Beginning balance (in shares) at Dec. 31, 2024	33,629,169	33,629,169
Beginning balance at Dec. 31, 2024	$ 1,366,974	$ 34	827,796	537,184	1,960
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 41,226
Ending balance (in shares) at Jun. 30, 2025	35,287,080	35,287,080
Ending balance at Jun. 30, 2025	$ 1,465,971	$ 35	914,330	549,646	1,960
Beginning balance (in shares) at Mar. 31, 2025		34,182,785
Beginning balance at Mar. 31, 2025	1,397,337	$ 34	855,759	539,584	1,960
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	24,675			24,675
Stock-based compensation	1,455		1,464	(9)
Issuance of restricted and deferred stock units (in shares)		16,702
Issuance of restricted and deferred stock units	(61)		(61)
Common stock issuance, net of costs (in shares)		1,087,593
Common stock issuance, net of costs	57,169	$ 1	57,168
Dividends paid	$ (14,604)			(14,604)
Ending balance (in shares) at Jun. 30, 2025	35,287,080	35,287,080
Ending balance at Jun. 30, 2025	$ 1,465,971	$ 35	$ 914,330	$ 549,646	$ 1,960